Riskreveal Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$13M
- Investors
-
1
Riskreveal General Information
Description
Developer of a genomic mutation detection technology designed to identify cancer and other disease-causing mutations from patient biopsy samples. The company's technology offers molecular stratification test and aggregates genomic information advances the understanding of etiology, and detects genomic mutations, providing oncologists with rapid, accurate and actionable information, enabling physicians to identify patients with IA-IIA non-squamous non-small cell lung cancer (NSCLC) who may be at low- or high risk of having a recurrence and treat their patients in an enhanced way.
Contact Information
Website
www.razorgenomics.com(Operating Subsidiary)
Corporate Office
- 111 10th Avenue South
- Suite 102, Room 123
- Nashville, TN 37203
- United States
Corporate Office
- 111 10th Avenue South
- Suite 102, Room 123
- Nashville, TN 37203
- United States
Riskreveal Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 22-Feb-2023 | $13M | Completed | Generating Revenue | ||
| 5. Merger/Acquisition | 25-Feb-2021 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 05-Sep-2019 | Completed | Generating Revenue | |||
| 3. Early Stage VC | Completed | Generating Revenue | ||||
| 2. Early Stage VC (Series A) | 20-Jun-2016 | $3.67M | $4.37M | Completed | Generating Revenue | |
| 1. Seed Round | 10-Jul-2014 | $700K | $700K | Completed | Generating Revenue |
Riskreveal Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Riskreveal Comparisons
Industry
Financing
Details
Riskreveal Competitors (25)
One of Riskreveal’s 25 competitors is Decipher Urologic Cancers, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Decipher Urologic Cancers | Formerly VC-backed | San Diego, CA | ||||
| T2 Biosystems | Formerly VC-backed | Lexington, MA | ||||
| CirculoGene | Venture Capital-Backed | Birmingham, AL | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| MultiplexDX | Venture Capital-Backed | Rockville, MD |
Riskreveal Patents
Riskreveal Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20130059747-A1 | Multigene prognostic assay for lung cancer | Active | 01-Jul-2011 | ||
| US-9476098-B2 | Multigene prognostic assay for lung cancer | Active | 01-Jul-2011 |
Riskreveal Signals
Riskreveal Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Foothill Ventures | Venture Capital | Minority | ||
| TSV Capital (Los Altos) | Venture Capital | Minority | ||
| UCSF Innovation Ventures | Venture Capital | Minority | ||
| Venture Leader Group | Venture Capital | Minority |
Riskreveal FAQs
-
When was Riskreveal founded?
Riskreveal was founded in 2014.
-
Where is Riskreveal headquartered?
Riskreveal is headquartered in Nashville, TN.
-
What is the size of Riskreveal?
Riskreveal has 4 total employees.
-
What industry is Riskreveal in?
Riskreveal’s primary industry is Diagnostic Equipment.
-
Is Riskreveal a private or public company?
Riskreveal is a Private company.
-
What is the current valuation of Riskreveal?
The current valuation of Riskreveal is .
-
What is Riskreveal’s current revenue?
The current revenue for Riskreveal is .
-
How much funding has Riskreveal raised over time?
Riskreveal has raised $4.37M.
-
Who are Riskreveal’s investors?
Foothill Ventures, TSV Capital (Los Altos), UCSF Innovation Ventures, and Venture Leader Group have invested in Riskreveal.
-
Who are Riskreveal’s competitors?
Decipher Urologic Cancers, T2 Biosystems, CirculoGene, Foundation Medicine, and MultiplexDX are some of the 25 competitors of Riskreveal.
-
When was Riskreveal acquired?
Riskreveal was acquired on 22-Feb-2023.
-
Who acquired Riskreveal?
Riskreveal was acquired by Dragon Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process